Clinical Trial Update: A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating early clinical efficacy signals of a GLP-1 receptor agonist given with a levonorgestrel-releasing intrauterine system in obese pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Intraepithelial Neoplasia

Drugs mentioned

• GLP-1 receptor agonist (unspecified)
• Levonorgestrel-Releasing Intrauterine System (levonorgestrel-releasing intrauterine system)

Snippet

Sponsor: University of Florida | Conditions: Endometrioid Endometrial Adenocarcinoma | Phase 2 | Status: RECRUITING